Depot medroxyprogesterone acetate and osteoporosis. Smoking may explain findings
- PMID: 8179699
- PMCID: PMC2539378
Depot medroxyprogesterone acetate and osteoporosis. Smoking may explain findings
Comment in
-
Depot medroxyprogesterone and bone density.BMJ. 1994 Jun 11;308(6943):1567-8. doi: 10.1136/bmj.308.6943.1567a. BMJ. 1994. PMID: 8068107 Free PMC article. No abstract available.
Comment on
-
Recovery of bone density in women who stop using medroxyprogesterone acetate.BMJ. 1994 Jan 22;308(6923):247-8. doi: 10.1136/bmj.308.6923.247. BMJ. 1994. PMID: 8111260 Free PMC article.
Similar articles
-
ACOG Committee Opinion No. 415: Depot medroxyprogesterone acetate and bone effects.Obstet Gynecol. 2008 Sep;112(3):727-30. doi: 10.1097/AOG.0b013e318188d1ec. Obstet Gynecol. 2008. PMID: 18757687 No abstract available.
-
Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning.J Pediatr Adolesc Gynecol. 2005 Jun;18(3):183. doi: 10.1016/j.jpag.2005.03.007. J Pediatr Adolesc Gynecol. 2005. PMID: 15970252 No abstract available.
-
Bone mineral density and DMPA.J Reprod Med. 2002 Sep;47(9 Suppl):795-9. J Reprod Med. 2002. PMID: 12380409 Review.
-
Depot medroxyprogesterone acetate and osteoporosis. Monitor serum oestradiol concentration in users.BMJ. 1994 Mar 12;308(6930):717. doi: 10.1136/bmj.308.6930.717. BMJ. 1994. PMID: 8142810 Free PMC article. No abstract available.
-
DMPA's effect on bone mineral density: A particular concern for adolescents.J Fam Pract. 2009 May;58(5):E1-8. J Fam Pract. 2009. PMID: 19442384 Review.
Cited by
-
Depot medroxyprogesterone and bone density.BMJ. 1994 Jun 11;308(6943):1567-8. doi: 10.1136/bmj.308.6943.1567a. BMJ. 1994. PMID: 8068107 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical